Total Payments
$2,187
2023 Payments
$50.42
Companies
21
Transactions
94
Medicare Patients
4,366
Medicare Billing
$268,206
Payment Breakdown by Category
Food & Beverage$2,000 (91.5%)
Education$186.58 (8.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,000 | 91 | 91.5% |
| Education | $186.58 | 3 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $621.60 | 28 | $0 (2023) |
| NeoTract Inc. | $449.46 | 5 | $0 (2020) |
| Teleflex LLC | $326.15 | 6 | $0 (2023) |
| Janssen Biotech, Inc. | $224.00 | 17 | $0 (2019) |
| Amgen Inc. | $92.67 | 6 | $0 (2018) |
| ABBVIE INC. | $92.33 | 6 | $0 (2022) |
| PFIZER INC. | $85.85 | 8 | $0 (2019) |
| C. R. Bard, Inc. & Subsidiaries | $48.97 | 1 | $0 (2018) |
| Blue Earth Diagnostics Limited | $42.66 | 2 | $0 (2019) |
| MEDIVATION INC. | $30.48 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $50.42 | 3 | Astellas Pharma US Inc ($30.42) |
| 2022 | $276.95 | 10 | Teleflex LLC ($173.93) |
| 2021 | $160.38 | 3 | Teleflex LLC ($132.22) |
| 2020 | $339.43 | 6 | NeoTract Inc. ($202.69) |
| 2019 | $578.73 | 19 | Astellas Pharma US Inc ($225.19) |
| 2018 | $457.19 | 29 | Janssen Biotech, Inc. ($111.91) |
| 2017 | $323.47 | 24 | Janssen Biotech, Inc. ($73.28) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/31/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Urology | ||||||
| 05/30/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Interventional Urology | ||||||
| 04/06/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Urology | ||||||
| 12/07/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Urology | ||||||
| 11/17/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $12.19 | General |
| Category: Urology | ||||||
| 10/13/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $11.70 | General |
| Category: Urology | ||||||
| 10/11/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Urology | ||||||
| 09/15/2022 | Becton, Dickinson and Company | — | Food and Beverage | In-kind items and services | $14.92 | General |
| 09/07/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $139.70 | General |
| Category: Interventional Urology | ||||||
| 08/09/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Interventional Urology | ||||||
| 07/13/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/01/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Interventional Urology | ||||||
| 03/29/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/23/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $112.62 | General |
| Category: Interventional Urology | ||||||
| 06/16/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: UROLOGY | ||||||
| 05/13/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Interventional Urology | ||||||
| 11/06/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $112.83 | General |
| Category: Interventional Urology | ||||||
| 02/26/2020 | Astellas Pharma US Inc | — | Education | In-kind items and services | $88.00 | General |
| 02/21/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: UROLOGY | ||||||
| 02/04/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: UROLOGY | ||||||
| 01/16/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $89.86 | General |
| Category: Interventional Urology | ||||||
| 01/10/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: UROLOGY | ||||||
| 12/20/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.99 | General |
| 12/03/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: UROLOGY | ||||||
| 12/02/2019 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $96.93 | General |
| Category: Interventional Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 19 | 1,478 | 2,006 | $243,166 | $64,762 |
| 2021 | 29 | 1,987 | 2,901 | $483,300 | $153,598 |
| 2020 | 13 | 901 | 1,236 | $216,513 | $49,846 |
Total Patients
4,366
Total Services
6,143
Medicare Billing
$268,206
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 254 | $54,864 | $18,366 | 33.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 65 | 75 | $51,120 | $12,345 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 163 | $23,276 | $9,533 | 41.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 57 | 57 | $18,947 | $6,595 | 34.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 129 | 163 | $14,474 | $2,964 | 20.5% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2022 | 15 | 67 | $18,412 | $2,591 | 14.1% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2022 | 15 | 15 | $11,862 | $2,345 | 19.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $5,370 | $1,976 | 36.8% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 347 | 561 | $8,752 | $1,756 | 20.1% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 12 | 26 | $6,458 | $1,168 | 18.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 136 | 177 | $12,107 | $1,103 | 9.1% |
| 74018 | X-ray of abdomen, 1 view | Office | 2022 | 58 | 74 | $4,262 | $977.50 | 22.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2022 | 39 | 39 | $3,463 | $743.83 | 21.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 19 | $1,642 | $715.91 | 43.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 164 | 201 | $2,894 | $595.92 | 20.6% |
| 51701 | Insertion of temporary bladder tube | Office | 2022 | 12 | 14 | $2,722 | $435.07 | 16.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 25 | $1,650 | $266.59 | 16.2% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 11 | 12 | $734.40 | $229.24 | 31.2% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2022 | 16 | 39 | $156.00 | $57.45 | 36.8% |
| J9202 | Goserelin acetate implant, per 3.6 mg | Office | 2021 | 15 | 78 | $83,820 | $32,908 | 39.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 265 | 370 | $65,623 | $32,394 | 49.4% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 82 | 90 | $49,594 | $14,553 | 29.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 143 | 172 | $20,171 | $9,974 | 49.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 90 | 90 | $24,650 | $9,365 | 38.0% |
| 52601 | Electro-removal of prostate through bladder canal (urethra) with control of bleeding using an endoscope | Facility | 2021 | 16 | 16 | $35,052 | $8,704 | 24.8% |
About Dr. Thomas Pearson, M.D
Dr. Thomas Pearson, M.D is a Urology healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689676579.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Pearson, M.D has received a total of $2,187 in payments from pharmaceutical and medical device companies, with $50.42 received in 2023. These payments were reported across 94 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,000).
As a Medicare-enrolled provider, Pearson has provided services to 4,366 Medicare beneficiaries, totaling 6,143 services with total Medicare billing of $268,206. Data is available for 3 years (2020–2022), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Springfield, MO
- Active Since 08/11/2005
- Last Updated 03/14/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1689676579
Products in Payments
- UroLift (Device) $416.04
- XTANDI (Drug) $246.12
- UROLIFT (Device) $193.93
- ZYTIGA (Drug) $160.28
- MYRBETRIQ (Drug) $137.36
- UroLift System (Device) $132.22
- Myrbetriq (Drug) $123.23
- Prolia (Biological) $92.67
- Erleada (Drug) $72.31
- Axumin (Drug) $42.66
- VIAGRA (Drug) $41.18
- LUPRON DEPOT (Drug) $38.10
- Urolift - UL400 (Device) $33.42
- TOVIAZ (Drug) $31.81
- Lupron (Drug) $31.35
- GEMTESA (Drug) $23.89
- Androgel (Drug) $22.88
- LoFric (Device) $19.09
- REZUM (Device) $17.73
- AVYCAZ (Drug) $15.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Springfield
Bryan Mehlhaff, Md, MD
Urology — Payments: $1.5M
Urology $1.5M
Kevin Mcvary, Md, MD
Urology — Payments: $405,504
Urology $405,504
Bradley Schwartz, M.d, M.D
Urology — Payments: $105,537
Urology $105,537
Robert Nadler, Md, MD
Urology — Payments: $93,691
Urology $93,691
Kevin Krughoff
Urology — Payments: $54,104
Urology $54,104
Dr. Eric Espinosa
Urology — Payments: $23,023
Urology $23,023